Status | Study |
Recruiting |
Study Name: Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients Condition: Diabetes Mellitus, Adult-Onset Diabetes Complications Date: 2015-05-25 |
Recruiting |
Study Name: According CTC to Compare the Influences of Different Methods to Remove the PDAC Condition: Carcinoma, Pancreatic Ductal Circulating Tumor Cells Date: 2015-05-14 Interventions: Procedure: routine surgery To |
Recruiting |
Study Name: An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy Condition: Biliary Tract Diseases Stomach Neoplasms Date: 2014-09-18 Interventions: Device: ExSpiron Respiratory Variation Monitor Non-invasive monitoring of minute ventilation, tidal volu |
Terminated |
Study Name: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer Condition: Resectable Pancreatic Cancer Pancreatic Ductal Carcinoma Date: 2014-09-15 Interventions: Drug: FOLFIRINOX Drug: Gemcitabine/nab-Pac |
Enrolling by invitation |
Study Name: Clinical Trial of Pancreatic Cancer in Stockholm. Condition: Pancreatic Cancer Date: 2014-06-11 Interventions: Procedure: Pancreatic Surgery Surgical removal of the pancreatic tumour (cancer) in the intervention gro |
Completed |
Study Name: Circulating Tumor Cells in Operative Blood Condition: Carcinoma, Pancreatic Ductal Date: 2014-05-27 Interventions: Procedure: Peripheral/Central Venous Blood Draw |
Active, not recruiting |
Study Name: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Condition: Metastatic Pancreatic Cancer Date: 2013-04-22 Interventions: Drug: PEGPH20+nab-paclitaxel+gemcitabine |
Completed |
Study Name: Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) Condition: Carcinoma, Pancreatic Ductal Date: 2013-03-04 Interventions: Drug: Atu027 & gemcitabine in lead in safety period |
Completed |
Study Name: A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 Condition: Pancreatic Cancer Carcinoma, Pancreatic Ductal Date: 2012-05-29 Interventions: Biological: AGS-1C4D4 Intraven |
Completed |
Study Name: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer Condition: Pancreatic Ductal Adenocarcinoma Date: 2012-04-13 Interventions: Drug: INNO-206 INNO-206 at a total dose of 350 mg/m2 (260 mg/m2 doxorubicin equivalent) will be administ |